Quantitative susceptibility mapping in the abdomen as an imaging biomarker of hepatic iron overload
Magnetic Resonance in Medicine2014Vol. 74(3), pp. 673–683
Citations Over TimeTop 10% of 2014 papers
Abstract
We have developed and demonstrated initial validation of QSM in the abdomen as an imaging biomarker of hepatic iron overload.
Related Papers
- → Evaluation of an imaging biomarker, Dixon quantitative chemical shift imaging, in Gaucher disease: lessons learned(2014)20 cited
- → Biomarker Evaluation for Prognostic Stratification of Patients with Covid-19: the Added Value of Quantitative Chest Ct(2022)2 cited
- → S2‐02‐05: Role of biomarkers in MCI(2010)
- → SP0033 What Makes A Good Biomarker?(2014)
- → Inter-tumor validation, through advanced MRI and circulating biomarkers, of plasma Tie2 as the vascular response biomarker for bevacizumab.(2017)